2seventy bio Inc. (TSVT): Price and Financial Metrics


2seventy bio Inc. (TSVT): $14.07

0.19 (+1.37%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add TSVT to Watchlist
Sign Up

Industry: Biotech


Ranked

of

in industry

TSVT Stock Price Chart Interactive Chart >

Price chart for TSVT

TSVT Price/Volume Stats

Current price $14.07 52-week high $64.00
Prev. close $13.88 52-week low $9.91
Day low $13.75 Volume 696,000
Day high $14.69 Avg. volume 506,916
50-day MA $12.70 Dividend yield N/A
200-day MA $0.00 Market Cap 529.34M

2seventy bio Inc. (TSVT) Company Bio


2seventy Bio, Inc. operates as cell and gene therapy company. It is focused on the research, development, and commercialization of transformative treatments for cancer. The company was founded on April 26, 2021 and is headquartered in Cambridge, MA.


TSVT Latest News Stream


Event/Time News Detail
Loading, please wait...

TSVT Latest Social Stream


Loading social stream, please wait...

View Full TSVT Social Stream

Latest TSVT News From Around the Web

Below are the latest news stories about 2seventy bio Inc that investors may wish to consider to help them evaluate TSVT as an investment opportunity.

2seventy bio Announces Key Management Appointments

CAMBRIDGE, Mass., February 14, 2022--2seventy bio, Inc. (NASDAQ: TSVT) announced that Steven Bernstein, M.D. will join the company effective today and assume the role of chief medical officer (CMO). Also announced today, Susan Abu-Absi, Ph.D. has been appointed chief technology & manufacturing officer at 2seventy bio.

Yahoo | February 14, 2022

2seventy bio to Participate in Upcoming Healthcare Conferences

CAMBRIDGE, Mass., February 14, 2022--2seventy bio, Inc. (Nasdaq: TSVT) announced today that it will present at the following upcoming investor conferences:

Yahoo | February 14, 2022

Do Institutions Own 2seventy bio, Inc. (NASDAQ:TSVT) Shares?

Every investor in 2seventy bio, Inc. ( NASDAQ:TSVT ) should be aware of the most powerful shareholder groups. Generally...

Yahoo | February 11, 2022

Virginia Retirement Systems Et Al Buys Wolfspeed Inc, Orion Office REIT Inc, Kyndryl Holdings ...

Richmond, VA, based Investment company Virginia Retirement Systems Et Al (Current Portfolio) buys Wolfspeed Inc, Orion Office REIT Inc, Kyndryl Holdings Inc, 2seventy bio Inc, Loyalty Ventures Inc, sells American Water Works Co Inc, Johnson & Johnson, Activision Blizzard Inc, Intuit Inc, Dollar General Corp during the 3-months ended 2021Q4, according to the most recent filings of the investment company, Virginia Retirement Systems Et Al.

Yahoo | February 3, 2022

Adaptimmune Announces Appointment of Cintia Piccina as Chief Commercial Officer

PHILADELPHIA and OXFORDSHIRE, United Kingdom, Jan. 26, 2022 (GLOBE NEWSWIRE) -- Adaptimmune Therapeutics plc (Nasdaq:ADAP), a leader in T-cell therapy to treat cancer, today announces the appointment of Cintia Piccina as Chief Commercial Officer effective January 31, 2022. “I am delighted to welcome Cintia to our leadership team. She brings extensive commercial experience, including in cell and gene therapy, that will be key as we prepare to submit our first BLA for afami-cel this year, and buil

Yahoo | January 26, 2022

Read More 'TSVT' Stories Here

TSVT Price Returns

1-mo 20.67%
3-mo -19.51%
6-mo -41.11%
1-year N/A
3-year N/A
5-year N/A
YTD -45.10%
2021 N/A
2020 N/A
2019 N/A
2018 N/A
2017 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.4687 seconds.